How effective is domperidone at reducing symptoms of gastrooesophageal reflux in infants?

Archives of Disease in Childhood

Volumn 97, Issue 8, 2012, Pages 752-755

  Scott, Bryonnie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; METOCLOPRAMIDE; PLACEBO; ANTIEMETIC AGENT;

BREAST FEEDING; CASE REPORT; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; INFANT; INFORMATION RETRIEVAL; MALE; MEDLINE; NOTE; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VOMITING; EVIDENCE BASED MEDICINE; PATIENT POSITIONING; REVIEW; TREATMENT OUTCOME;

ANTIEMETICS; DOMPERIDONE; EVIDENCE-BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; MALE; PATIENT POSITIONING; TREATMENT OUTCOME; VOMITING;

EID: 84864685248     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-302183     Document Type: Note

References (14)

1. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005;59:725-9. (Pubitemid 40835508)
2. Bines JE, Quinlan JE, Treves S, et al. Efficacy of domperidone in infants and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992;14:400-5.
3. Carroccio A, Iacono G, Montalto G, et al. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo. Scand J Gastroenterol 1994;29:300-4. (Pubitemid 24128375)
4. De Loore L, Van Ravenstayn H. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979;55(Suppl 1):40-2.
5. Clara R. Chronic regurgitation and vomiting treated with domperidone. A multicenter evaluation. Acta Paediatric Belg 1979;32:203-7. (Pubitemid 10211360)
6. Hegar B, Alatas S, Advani N, et al. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastrooesophageal reflux: a pilot study. Acta Paediatr 2009;98:750-5.
7. Cresi F, Marinaccio C, Russo MC, et al. Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring. J Perinatol 2008;28:766-70.
8. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 1997;151:569-72. (Pubitemid 27262280)
9. Carre IJ. Clinical significance of gastro-oesophageal reflux. Arch Dis Child 1984;59:911-2. (Pubitemid 14018112)
10. Vandenplas Y, Ashkenazi A, Belli D, et al. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN). Eur J Pediatr 1993;152:704-11. (Pubitemid 23257899)
11. Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 2002;51:475-9.
12. Davidson G. The role of lower esophageal sphincter function and dysmotility in gastroesophageal reflux in premature infants and in the first year of life. J Pediatr Gastroenterol Nutr 2003;37 Suppl 1:S17-22.
13. Ausgood C, MacLennon S. Cisapride treatment for gastroesophageal reflux in children (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2000.
14. Vandenplas Y, Sacré-Smits L. Gastro-oesophageal reflux in infants. Evaluation of treatment by pH monitoring. Eur J Pediatr 1987;146:504-7. (Pubitemid 18053155)